News
Cellugy Raises $9.25M to Replace Microplastic-Generating Ingredients in Cosmetics
Denmark-based Cellugy secured $9.25M in EU LIFE Programme funding to scale production of EcoFLEXY, a cellulose-based rheology modifier replacing fossil-based carbomers and aiming to eliminate up to 1,289 tons of microplastics annually by 2034.
Caterpillar factories produce fluorescent nanocarbons
RIKEN Center for Sustainable Resource Science (CSRS) have successfully used insects as mini molecule-making factories, marking a breakthrough in chemical engineering. Referred to as “in-insect synthesis,” this technique offers a new way to create and modify complex molecules, which will generate new opportunities for the discovery, development, and application of non-natural molecules, such as nanocarbons.
Scientists build first genetic “toggle switch” for plants, paving the way for smarter farming
Synthetic biologists design and build new segments of DNA that can then be inserted into living organisms to work like circuits in electronics or a computer. Just as a switch is used to turn a lightbulb on or off in an electric circuit, the team’s “toggle” turns genes on and off when an external signal is applied.
EV Biotech introduces ArtemisAI for smarter microbial engineering
ArtemisAI combines constraint-based modeling with machine learning. It creates a hybrid system that provides predictive and interpretable insights. Even with limited data, it helps make faster, smarter decisions in microbial engineering and media optimization.
Signify Bio Launches With an Oversubscribed $15 Million Initial Financing and Strategic Partnership With UTSW Focused on Nucleic Acid Enabled Protein Therapeutics
Signify’s mission is to create personalized medicines for all by combining the promise of signal peptide engineered control with the speed and power of mRNA encoded design.
IDT Unveils Custom Solutions Program for Tailored Synthetic Biology Innovation
Designed to accelerate design–build–test–iterate cycles, IDT’s program offers flexible, collaborative development outside traditional high-throughput constraints, backed by a dedicated team and facility.
"Toyobo signs joint development agreement with DMC Biotechnologies Inc. to develop and commercialize sustainable, key compounds for plastic raw materials"
The two companies aim to develop and commercialize sustainable key chemical compounds to be used as raw materials for general-purpose plastics by applying synthetic biology technologies to microorganisms.
Antheia Raises $56 Million in Series C Financing to Fuel Global Commercialization Strategy
The new financing will be used to expand commercialization of Antheia’s first product, thebaine, and launch additional products from the company’s pipeline of 70+ biosynthetic pharmaceutical ingredients, which spans seven therapeutic areas and prioritizes essential medicines in or at risk of shortage.
Industry leaders use Knowledge Hub to explore 650+ Synthetic Biology news
Gain unparalleled insights, and drive your innovation forward.
Let’s shape tomorrow, today!